it is shown that daily oral administration of 5 -- 10 mg of an antidiabetic biguanide-phenformin ( phenethyl-biguanide ) for 2.5 -- 5 months suppressed dmba-induced mammary tumour development in rats considerably .
C0005382
biguanide
C0031404
phenformin